The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Expression and Transcriptome Sequencing Market Research Report 2024
Synopsis
Gene expression refers to the process by which information encoded in a gene is used to create functional gene products, such as proteins or non-coding RNAs. It involves the transcription of DNA into RNA and the subsequent translation of RNA into proteins. Gene expression is a fundamental process that plays a crucial role in various biological processes, including development, growth, and maintenance of tissues, as well as response to environmental stimuli.
Global Gene Expression and Transcriptome Sequencing market is projected to reach US$ 9188.6 million in 2029, increasing from US$ 4124 million in 2022, with the CAGR of 12.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Expression and Transcriptome Sequencing market research.
Key companies engaged in the Gene Expression and Transcriptome Sequencing industry include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Gene Expression and Transcriptome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gene Expression and Transcriptome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Expression and Transcriptome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
Gene Expression
Transcriptome Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gene Expression and Transcriptome Sequencing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Gene expression refers to the process by which information encoded in a gene is used to create functional gene products, such as proteins or non-coding RNAs. It involves the transcription of DNA into RNA and the subsequent translation of RNA into proteins. Gene expression is a fundamental process that plays a crucial role in various biological processes, including development, growth, and maintenance of tissues, as well as response to environmental stimuli.
Global Gene Expression and Transcriptome Sequencing market is projected to reach US$ 9188.6 million in 2029, increasing from US$ 4124 million in 2022, with the CAGR of 12.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Expression and Transcriptome Sequencing market research.
Key companies engaged in the Gene Expression and Transcriptome Sequencing industry include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Gene Expression and Transcriptome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Gene Expression and Transcriptome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Expression and Transcriptome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
Gene Expression
Transcriptome Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gene Expression and Transcriptome Sequencing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Expression and Transcriptome Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene Expression
1.2.3 Transcriptome Sequencing
1.3 Market by Application
1.3.1 Global Gene Expression and Transcriptome Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Expression and Transcriptome Sequencing Market Perspective (2018-2029)
2.2 Gene Expression and Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Gene Expression and Transcriptome Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Expression and Transcriptome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Gene Expression and Transcriptome Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Gene Expression and Transcriptome Sequencing Market Dynamics
2.3.1 Gene Expression and Transcriptome Sequencing Industry Trends
2.3.2 Gene Expression and Transcriptome Sequencing Market Drivers
2.3.3 Gene Expression and Transcriptome Sequencing Market Challenges
2.3.4 Gene Expression and Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Expression and Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Gene Expression and Transcriptome Sequencing Players by Revenue (2018-2023)
3.1.2 Global Gene Expression and Transcriptome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Gene Expression and Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Expression and Transcriptome Sequencing Revenue
3.4 Global Gene Expression and Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Gene Expression and Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Expression and Transcriptome Sequencing Revenue in 2022
3.5 Gene Expression and Transcriptome Sequencing Key Players Head office and Area Served
3.6 Key Players Gene Expression and Transcriptome Sequencing Product Solution and Service
3.7 Date of Enter into Gene Expression and Transcriptome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Expression and Transcriptome Sequencing Breakdown Data by Type
4.1 Global Gene Expression and Transcriptome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Gene Expression and Transcriptome Sequencing Forecasted Market Size by Type (2024-2029)
5 Gene Expression and Transcriptome Sequencing Breakdown Data by Application
5.1 Global Gene Expression and Transcriptome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Gene Expression and Transcriptome Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
6.2 North America Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
6.4 North America Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
7.2 Europe Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
7.4 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
9.2 Latin America Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
9.4 Latin America Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Gene Expression and Transcriptome Sequencing Introduction
11.2.4 Illumina Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Gene Expression and Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Gene Expression and Transcriptome Sequencing Introduction
11.5.4 Roche Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Gene Expression and Transcriptome Sequencing Introduction
11.6.4 GE Healthcare Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Gene Expression and Transcriptome Sequencing Introduction
11.8.4 Fluidigm Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
